FDA Orange Book · active-ingredient family
Sodium tetradecyl sulfate
Sodium tetradecyl sulfate is approved as 1 brand and 2 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:SOTRADECOL · NDA 005970
1
Brand (NDA)
2
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| SOTRADECOLRLD×2 | ELKINS SINN | NDA 005970 | — | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (2)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| SODIUM TETRADECYL SULFATE | HIKMA | ANDA 209937 | AP | Dec 09, 2019 | |
| SOTRADECOL×2 | MYLAN INSTITUTIONAL | ANDA 040541 | — | Nov 12, 2004 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Sodium tetradecyl sulfate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

